Breaking News Instant updates and real-time market news.

CPIX

Cumberland

$3.82 /

+0.02 (+0.53%)

09:36
03/17/20
03/17
09:36
03/17/20
09:36

Cumberland says Caldolor demonstrates favorable safety profile in newborns

Cumberland Pharmaceuticals announced topline results from a clinical study evaluating the safety and pharmacokinetics of Caldolor Injection in children ranging from birth to six months of age. Topline results from this study indicate that Caldolor was well tolerated overall in this patient population, with no safety concerns noted. The open-label trial enrolled 24 newborns at four medical centers across the country. The study data indicated that the pharmacokinetics of Caldolor behaves similarly between these very young children and those greater than 6 months of age. Next steps include finalizing the full study report for submission to the FDA and then determining whether an additional pediatric indication will be available. At the time of Caldolor's New Drug Application approval, the FDA requested a series of Phase IV studies to evaluate the product in pediatric patients. Cumberland had previously completed a pain and a fever study leading to an expanded Caldolor label - with FDA approval - for use in children 6 months and older. Cumberland completed the last of these requirements through this clinical study of the use of Caldolor in the youngest of patients.

  • 18

    Mar

TODAY'S FREE FLY STORIES

Recommendations
Wendy's price target raised to $27 from $25 at Piper Sandler » 06:06
01/21/21
01/21
06:06
01/21/21
06:06
WEN

Wendy's

$21.45 /

-0.33 (-1.52%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WEN Wendy's
$21.45 /

-0.33 (-1.52%)

WEN Wendy's
$21.45 /

-0.33 (-1.52%)

01/19/21 Goldman Sachs
Wendy's initiated with a Neutral at Goldman Sachs
01/11/21 Evercore ISI
Wendy's downgraded to In Line as Evercore is 'searching for a new narrative'
01/11/21 Evercore ISI
Wendy's downgraded to In Line from Outperform at Evercore ISI
01/07/21
Fly Intel: Top five analyst downgrades
WEN Wendy's
$21.45 /

-0.33 (-1.52%)

WEN Wendy's
$21.45 /

-0.33 (-1.52%)

WEN Wendy's
$21.45 /

-0.33 (-1.52%)

Upgrade
Under Armour upgraded to Buy from Hold at Deutsche Bank » 06:06
01/21/21
01/21
06:06
01/21/21
06:06
UAA

Under Armour

/

+

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UAA Under Armour
/

+

UAA Under Armour
/

+

01/15/21 B. Riley Securities
Under Armour price target raised to $15 from $13 at B. Riley Securities
01/07/21 JPMorgan
Under Armour price target raised to $19 from $17 at JPMorgan
01/04/21 Pivotal Research
Under Armour upgraded to Buy from Hold at Pivotal Research
12/09/20 UBS
Under Armour price target raised to $17 from $10 at UBS
UAA Under Armour
/

+

UAA Under Armour
/

+

UAA Under Armour
/

+

UAA Under Armour
/

+

Upgrade
Capri Holdings upgraded to Buy from Hold at Deutsche Bank » 06:06
01/21/21
01/21
06:06
01/21/21
06:06
CPRI

Capri Holdings

$43.57 /

+1.045 (+2.46%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPRI Capri Holdings
$43.57 /

+1.045 (+2.46%)

CPRI Capri Holdings
$43.57 /

+1.045 (+2.46%)

01/07/21 JPMorgan
Capri Holdings price target raised to $43 from $34 at JPMorgan
01/07/21 Barclays
Capri Holdings upgraded to Overweight from Equal Weight at Barclays
01/04/21 Piper Sandler
Capri Holdings upgraded to Overweight from Neutral at Piper Sandler
12/30/20 Guggenheim
Capri Holdings price target raised to $48 from $28 at Guggenheim
CPRI Capri Holdings
$43.57 /

+1.045 (+2.46%)

CPRI Capri Holdings
$43.57 /

+1.045 (+2.46%)

CPRI Capri Holdings
$43.57 /

+1.045 (+2.46%)

CPRI Capri Holdings
$43.57 /

+1.045 (+2.46%)

Upgrade
Ciena upgraded to Buy from Neutral at BofA » 06:06
01/21/21
01/21
06:06
01/21/21
06:06
CIEN

Ciena

$52.86 /

+0.27 (+0.51%)

BofA upgraded Ciena to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CIEN Ciena
$52.86 /

+0.27 (+0.51%)

CIEN Ciena
$52.86 /

+0.27 (+0.51%)

01/13/21 Needham
Ciena price target raised to $65 from $58 at Needham
12/15/20 Morgan Stanley
Morgan Stanley upgrades 'laggard' Lumentum to Overweight
12/11/20 B. Riley Securities
Ciena price target raised to $51.50 from $46 at B. Riley Securities
12/11/20 Barclays
Ciena price target raised to $62 from $54 at Barclays
CIEN Ciena
$52.86 /

+0.27 (+0.51%)

CIEN Ciena
$52.86 /

+0.27 (+0.51%)

CIEN Ciena
$52.86 /

+0.27 (+0.51%)

Recommendations
Lemonade price target raised to $163 from $105 at Piper Sandler » 06:05
01/21/21
01/21
06:05
01/21/21
06:05
LMND

Lemonade

/

+

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LMND Lemonade
/

+

LMND Lemonade
/

+

11/23/20 Morgan Stanley
Root initiated with an Equal Weight at Morgan Stanley
11/12/20 Piper Sandler
Lemonade price target raised to $71 from $63 at Piper Sandler
11/02/20 Piper Sandler
Lemonade initiated with an Overweight at Piper Sandler
10/15/20
Fly Intel: Pre-market Movers
LMND Lemonade
/

+

  • 14
    Jan
  • 02
    Jul
LMND Lemonade
/

+

LMND Lemonade
/

+

LMND Lemonade
/

+

Downgrade
Unity Software downgraded to Underperform from Neutral at BofA » 06:05
01/21/21
01/21
06:05
01/21/21
06:05
U

Unity Software

$147.16 /

+2.46 (+1.70%)

BofA analyst Ryan Gee…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
U Unity Software
$147.16 /

+2.46 (+1.70%)

U Unity Software
$147.16 /

+2.46 (+1.70%)

01/15/21 Credit Suisse
Unity Software assumed with an Outperform at Credit Suisse
01/11/21 Piper Sandler
Unity Software price target raised to $150 from $115 at Piper Sandler
11/30/20 Oppenheimer
Unity Software downgraded to Perform at Oppenheimer
11/30/20 Oppenheimer
Unity Software downgraded to Perform from Outperform at Oppenheimer
U Unity Software
$147.16 /

+2.46 (+1.70%)

  • 18
    Sep
U Unity Software
$147.16 /

+2.46 (+1.70%)

U Unity Software
$147.16 /

+2.46 (+1.70%)

U Unity Software
$147.16 /

+2.46 (+1.70%)

Hot Stocks
DHT Holdings to acquire two VLCCs for $136M » 06:05
01/21/21
01/21
06:05
01/21/21
06:05
DHT

DHT Holdings

$5.47 /

-0.045 (-0.82%)

DHT Holdings announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DHT DHT Holdings
$5.47 /

-0.045 (-0.82%)

06/18/20
Fly Intel: Top five analyst downgrades
06/18/20 Stifel
DHT Holdings downgraded to Hold from Buy at Stifel
06/02/20 Fearnley
DHT Holdings downgraded to Hold from Buy at Fearnley
05/28/20 DNB Markets
DHT Holdings upgraded to Buy from Hold at DNB Markets
DHT DHT Holdings
$5.47 /

-0.045 (-0.82%)

DHT DHT Holdings
$5.47 /

-0.045 (-0.82%)

Downgrade
DuPont downgraded to Neutral from Buy at BofA » 06:04
01/21/21
01/21
06:04
01/21/21
06:04
DD

DuPont

$84.28 /

-0.19 (-0.22%)

BofA downgraded DuPont to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DD DuPont
$84.28 /

-0.19 (-0.22%)

DD DuPont
$84.28 /

-0.19 (-0.22%)

01/19/21 Deutsche Bank
DuPont named 'Catalyst Call: Buy Idea' at Deutsche Bank
01/14/21 JPMorgan
DuPont downgraded to Neutral, removed from Focus List at JPMorgan
01/14/21 DZ Bank
DuPont downgraded to Sell from Buy at DZ Bank
01/14/21 JPMorgan
DuPont downgraded to Neutral from Overweight at JPMorgan
DD DuPont
$84.28 /

-0.19 (-0.22%)

DD DuPont
$84.28 /

-0.19 (-0.22%)

DD DuPont
$84.28 /

-0.19 (-0.22%)

Hot Stocks
OraSure's saliva collection kit Included in FDA authorization for exome platform » 06:04
01/21/21
01/21
06:04
01/21/21
06:04
OSUR

OraSure

$13.33 /

-0.32 (-2.34%)

OraSure's Oragene…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OSUR OraSure
$13.33 /

-0.32 (-2.34%)

OSUR OraSure
$13.33 /

-0.32 (-2.34%)

12/22/20 Lake Street
Lake Street says OraSure test news disappointing, not due to fundamental issues
08/21/20
Fly Intel: Top five analyst initiations
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
OSUR OraSure
$13.33 /

-0.32 (-2.34%)

  • 03
    Jun
OSUR OraSure
$13.33 /

-0.32 (-2.34%)

OSUR OraSure
$13.33 /

-0.32 (-2.34%)

Hot Stocks
Banc of California reports Common Equity Tier 1 capital at 11.19%  06:03
01/21/21
01/21
06:03
01/21/21
06:03
BANC

Banc of California

$17.98 /

+0.19 (+1.07%)

 
ShowHide Related Items >><<
BANC Banc of California
$17.98 /

+0.19 (+1.07%)

BANC Banc of California
$17.98 /

+0.19 (+1.07%)

01/08/21 Piper Sandler
Banc of California price target raised to $21 from $19 at Piper Sandler
01/07/21 B. Riley Securities
Banc of California price target raised to $14 from $13 at B. Riley Securities
12/04/20 B. Riley Securities
Banc of California price target raised to $13 from $12 at B. Riley Securities
11/10/20 B. Riley Securities
Banc of California price target raised to $12 from $11 at B. Riley Securities
BANC Banc of California
$17.98 /

+0.19 (+1.07%)

Hot Stocks
Banc of California reports Q4 net interest margin of 3.38% » 06:02
01/21/21
01/21
06:02
01/21/21
06:02
BANC

Banc of California

$17.98 /

+0.19 (+1.07%)

A 29 basis points…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BANC Banc of California
$17.98 /

+0.19 (+1.07%)

01/08/21 Piper Sandler
Banc of California price target raised to $21 from $19 at Piper Sandler
01/07/21 B. Riley Securities
Banc of California price target raised to $14 from $13 at B. Riley Securities
12/04/20 B. Riley Securities
Banc of California price target raised to $13 from $12 at B. Riley Securities
11/10/20 B. Riley Securities
Banc of California price target raised to $12 from $11 at B. Riley Securities
BANC Banc of California
$17.98 /

+0.19 (+1.07%)

Upgrade
JPMorgan upgrades 'deep value stock' Diebold to Overweight » 06:02
01/21/21
01/21
06:02
01/21/21
06:02
DBD

Diebold

/

+

JPMorgan analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DBD Diebold
/

+

DBD Diebold
/

+

04:47 Today JPMorgan
Diebold upgraded to Overweight from Neutral at JPMorgan
10/27/20 JPMorgan
Diebold assumed with a Neutral at JPMorgan
10/27/20 JPMorgan
NCR Corp. upgraded to Overweight from Neutral at JPMorgan
05/11/20 JPMorgan
Diebold upgraded to Neutral on expense control at JPMorgan
DBD Diebold
/

+

Upgrade
NOV Inc. upgraded to Overweight from Equal Weight at Wells Fargo » 06:02
01/21/21
01/21
06:02
01/21/21
06:02
NOV

NOV Inc.

$13.66 /

-0.23 (-1.66%)

Wells Fargo upgraded NOV…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NOV NOV Inc.
$13.66 /

-0.23 (-1.66%)

NOV NOV Inc.
$13.66 /

-0.23 (-1.66%)

01/12/21 Citi
NOV Inc. upgraded to Buy from Neutral at Citi
01/11/21 Wolfe Research
National Oilwell upgraded to Outperform from Underperform at Wolfe Research
01/06/21 BofA
National Oilwell, Cactus upgraded as BofA positions for 'one last cycle'
01/06/21 BofA
National Oilwell upgraded to Neutral on energy mean reversion at BofA
NOV NOV Inc.
$13.66 /

-0.23 (-1.66%)

NOV NOV Inc.
$13.66 /

-0.23 (-1.66%)

NOV NOV Inc.
$13.66 /

-0.23 (-1.66%)

Earnings
Banc of California reports Q4 EPS 35c, consensus 18c » 06:01
01/21/21
01/21
06:01
01/21/21
06:01
BANC

Banc of California

$17.98 /

+0.19 (+1.07%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BANC Banc of California
$17.98 /

+0.19 (+1.07%)

01/08/21 Piper Sandler
Banc of California price target raised to $21 from $19 at Piper Sandler
01/07/21 B. Riley Securities
Banc of California price target raised to $14 from $13 at B. Riley Securities
12/04/20 B. Riley Securities
Banc of California price target raised to $13 from $12 at B. Riley Securities
11/10/20 B. Riley Securities
Banc of California price target raised to $12 from $11 at B. Riley Securities
BANC Banc of California
$17.98 /

+0.19 (+1.07%)

Downgrade
VMware downgraded to Sector Weight from Overweight at KeyBanc » 06:00
01/21/21
01/21
06:00
01/21/21
06:00
VMW

VMware

$132.61 /

+0.405 (+0.31%)

KeyBanc analyst Alex…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VMW VMware
$132.61 /

+0.405 (+0.31%)

VMW VMware
$132.61 /

+0.405 (+0.31%)

01/15/21 Evercore ISI
Evercore adds Dell Technologies to tactical Outperform list, ups target to $85
01/14/21 UBS
VMware price target lowered to $145 from $152 at UBS
01/14/21 BMO Capital
AMD downgraded to Underperform from Market Perform at BMO Capital
01/13/21 BMO Capital
VMware downgraded to Market Perform from Outperform at BMO Capital
VMW VMware
$132.61 /

+0.405 (+0.31%)

VMW VMware
$132.61 /

+0.405 (+0.31%)

VMW VMware
$132.61 /

+0.405 (+0.31%)

VMW VMware
$132.61 /

+0.405 (+0.31%)

Upgrade
Synaptics upgraded to Neutral with $110 target at JPMorgan » 05:59
01/21/21
01/21
05:59
01/21/21
05:59
SYNA

Synaptics

$103.86 /

+0.32 (+0.31%)

JPMorgan analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SYNA Synaptics
$103.86 /

+0.32 (+0.31%)

SYNA Synaptics
$103.86 /

+0.32 (+0.31%)

04:47 Today JPMorgan
Synaptics upgraded to Neutral from Underweight at JPMorgan
01/12/21 Susquehanna
Susquehanna names top five M&A candidates in Semi space
01/06/21 KeyBanc
Synaptics price target raised to $120 from $100 at KeyBanc
11/30/20 Cowen
Synaptics initiated with a Market Perform at Cowen
SYNA Synaptics
$103.86 /

+0.32 (+0.31%)

SYNA Synaptics
$103.86 /

+0.32 (+0.31%)

SYNA Synaptics
$103.86 /

+0.32 (+0.31%)

Downgrade
JPMorgan downgrades Maxar, says take profits after 85% rally » 05:58
01/21/21
01/21
05:58
01/21/21
05:58
MAXR

Maxar Technologies

$54.80 /

+0.06 (+0.11%)

JPMorgan analyst Benjamin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MAXR Maxar Technologies
$54.80 /

+0.06 (+0.11%)

MAXR Maxar Technologies
$54.80 /

+0.06 (+0.11%)

04:46 Today JPMorgan
Maxar Technologies downgraded to Neutral from Overweight at JPMorgan
12/11/20 Canaccord
Maxar Technologies price target raised to $40 from $36 at Canaccord
11/17/20
Fly Intel: Top five analyst upgrades
11/17/20 Canaccord
Maxar Technologies upgraded to Buy on improved visibility at Canaccord
MAXR Maxar Technologies
$54.80 /

+0.06 (+0.11%)

MAXR Maxar Technologies
$54.80 /

+0.06 (+0.11%)

MAXR Maxar Technologies
$54.80 /

+0.06 (+0.11%)

Earnings
Truist Financial reports Q4 adjusted EPS $1.18, consensus 97c » 05:49
01/21/21
01/21
05:49
01/21/21
05:49
TFC

Truist Financial

$51.61 /

-0.52 (-1.00%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TFC Truist Financial
$51.61 /

-0.52 (-1.00%)

TFC Truist Financial
$51.61 /

-0.52 (-1.00%)

01/07/21 Baird
Truist Financial downgraded to Neutral from Outperform at Baird
01/07/21 Jefferies
Jefferies downgrades 'more defensive' Truist Financial to Hold
01/07/21 Jefferies
Truist Financial downgraded to Hold from Buy at Jefferies
01/06/21 Deutsche Bank
Truist Financial price target raised to $56 from $46 at Deutsche Bank
TFC Truist Financial
$51.61 /

-0.52 (-1.00%)

TFC Truist Financial
$51.61 /

-0.52 (-1.00%)

TFC Truist Financial
$51.61 /

-0.52 (-1.00%)

Earnings
M&T Bank reports Q4 EPS $3.54, consensus $3.03 » 05:45
01/21/21
01/21
05:45
01/21/21
05:45
MTB

M&T Bank

$143.99 /

-2.12 (-1.45%)

Reports Q4 CET1 capital…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MTB M&T Bank
$143.99 /

-2.12 (-1.45%)

MTB M&T Bank
$143.99 /

-2.12 (-1.45%)

01/07/21 BofA
M&T Bank upgraded to Buy from Neutral at BofA
01/06/21 Deutsche Bank
M&T Bank price target raised to $155 from $135 at Deutsche Bank
01/04/21 Barclays
M&T Bank price target raised to $163 from $159 at Barclays
10/08/20 Wolfe Research
M&T Bank downgraded to Underperform from Peer Perform at Wolfe Research
MTB M&T Bank
$143.99 /

-2.12 (-1.45%)

MTB M&T Bank
$143.99 /

-2.12 (-1.45%)

Hot Stocks
Roche announces FDA acceptance of Genentech Esbriet sNDA » 05:35
01/21/21
01/21
05:35
01/21/21
05:35
RHHBY

Roche

$0.00 /

+ (+0.00%)

Genentech, a member of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

01/15/21 Deutsche Bank
Roche initiated with a Hold at Deutsche Bank
01/12/21 UBS
Roche price target lowered to CHF 355 from CHF 365 at UBS
01/11/21 Berenberg
Roche price target lowered to CHF 325 from CHF 350 at Berenberg
01/11/21 Benchmark
Phesgo EU approval/Horizon deal fuel Halozyme increased guidance, says Benchmark
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

Hot Stocks
Addex Therapeutics receives IND approval to start study in epilepsy » 05:33
01/21/21
01/21
05:33
01/21/21
05:33
ADXN

Addex Therapeutics

$10.49 /

+0.04 (+0.38%)

, JNJ

Johnson & Johnson

$162.30 /

-0.45 (-0.28%)

Addex Therapeutics (ADXN)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$162.30 /

-0.45 (-0.28%)

ADXN Addex Therapeutics
$10.49 /

+0.04 (+0.38%)

JNJ Johnson & Johnson
$162.30 /

-0.45 (-0.28%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
JNJ Johnson & Johnson
$162.30 /

-0.45 (-0.28%)

JNJ Johnson & Johnson
$162.30 /

-0.45 (-0.28%)

JNJ Johnson & Johnson
$162.30 /

-0.45 (-0.28%)

JNJ Johnson & Johnson
$162.30 /

-0.45 (-0.28%)

Hot Stocks
Galapagos announces NICE recommendation for Jyseleca on NHS » 05:27
01/21/21
01/21
05:27
01/21/21
05:27
GLPG

Galapagos

$108.63 /

+0.89 (+0.83%)

Galapagos announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GLPG Galapagos
$108.63 /

+0.89 (+0.83%)

GLPG Galapagos
$108.63 /

+0.89 (+0.83%)

01/19/21 Barclays
Galapagos price target raised to $125 from $85.50 at Barclays
01/19/21 Morgan Stanley
Galapagos upgraded to Overweight from Equal Weight at Morgan Stanley
12/18/20 Truist
Gilead price target lowered to $62 from $67 at Truist
12/17/20 Maxim
Galapagos price target lowered to $140 from $170 at Maxim
GLPG Galapagos
$108.63 /

+0.89 (+0.83%)

GLPG Galapagos
$108.63 /

+0.89 (+0.83%)

Recommendations
Pinnacle Financial price target raised to $80 from $60 at Keefe Bruyette » 05:27
01/21/21
01/21
05:27
01/21/21
05:27
PNFP

Pinnacle Financial

$72.53 /

+2.21 (+3.14%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PNFP Pinnacle Financial
$72.53 /

+2.21 (+3.14%)

PNFP Pinnacle Financial
$72.53 /

+2.21 (+3.14%)

01/04/21 Wells Fargo
Pinnacle Financial downgraded to Equal Weight from Overweight at Wells Fargo
12/15/20 JPMorgan
Pinnacle Financial upgraded to Overweight from Neutral at JPMorgan
11/16/20 Stephens
Pinnacle Financial resumed with an Overweight at Stephens
09/29/20 Truist
Truist raises price targets on select regional banks
PNFP Pinnacle Financial
$72.53 /

+2.21 (+3.14%)

Upgrade
Barings BDC upgraded to Buy from Hold at Jefferies » 05:25
01/21/21
01/21
05:25
01/21/21
05:25
BBDC

Barings BDC

$9.08 /

-0.025 (-0.27%)

Jefferies analyst Kyle…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BBDC Barings BDC
$9.08 /

-0.025 (-0.27%)

BBDC Barings BDC
$9.08 /

-0.025 (-0.27%)

08/18/20
Fly Intel: Top five analyst upgrades
08/17/20 Keefe Bruyette
Barings BDC upgraded to Outperform from Market Perform at Keefe Bruyette
06/24/20 Raymond James
Barings BDC upgraded to Strong Buy from Outperform at Raymond James
06/24/20 Raymond James
Barings BDC upgraded to Strong Buy from Outperform at Raymond James
BBDC Barings BDC
$9.08 /

-0.025 (-0.27%)

Upgrade
Freshpet upgraded to Outperform from Perform at Oppenheimer » 05:25
01/21/21
01/21
05:25
01/21/21
05:25
FRPT

Freshpet

$146.47 /

+2.39 (+1.66%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FRPT Freshpet
$146.47 /

+2.39 (+1.66%)

FRPT Freshpet
$146.47 /

+2.39 (+1.66%)

01/19/21 Stephens
Freshpet initiated with an Overweight at Stephens
01/19/21 JPMorgan
Freshpet price target raised to $170 from $160 at JPMorgan
01/14/21 Truist
Freshpet price target raised to $140 from $120 at Truist
01/11/21 Stifel
Freshpet price target raised to $160 from $120 at Stifel
FRPT Freshpet
$146.47 /

+2.39 (+1.66%)

  • 27
    Feb
FRPT Freshpet
$146.47 /

+2.39 (+1.66%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.